The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro and Autoimmune Conditions — What the Research Shows
If you have an autoimmune condition and are considering Mounjaro (tirzepatide) for weight management, understanding the current research is essential. While Mounjaro is licensed for weight management in UK adults, people with autoimmune conditions require careful medical assessment before starting treatment. This guide explains what clinical studies show about Mounjaro and autoimmune health, NHS safety monitoring requirements, and how to discuss eligibility with your GP or specialist.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What the Research Currently Shows About Mounjaro and Autoimmune Disease
Clinical trials for Mounjaro (tirzepatide) were not specifically designed to investigate autoimmune conditions, and larger autoimmune populations were largely excluded from the original SURMOUNT studies. However, post-marketing surveillance and real-world evidence are helping understand safety in this population.
Current evidence indicates:
- Mounjaro is not contraindicated in all autoimmune conditions — individual assessment is required
- Some GLP-1 medications (like semaglutide in Wegovy) have been studied in type 1 diabetes with generally positive safety results
- Tirzepatide's dual GIP/GLP-1 mechanism means safety data differs from single-agent GLP-1 drugs
- The MHRA maintains active surveillance for any signals of autoimmune flare or new-onset autoimmune disease
Because autoimmune conditions vary widely — from type 1 diabetes and coeliac disease to inflammatory bowel disease and lupus — eligibility for Mounjaro is assessed individually by a prescriber, not by blanket category.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS Assessment and Safety Monitoring for Autoimmune Patients
If you have an autoimmune condition, your GP or specialist must carry out a thorough clinical assessment before Mounjaro can be prescribed. This includes reviewing your specific condition, current medications, disease activity, and any previous adverse reactions to similar medications.
What happens in practice:
- Your medical history — including autoimmune diagnosis and treatment — is documented
- Baseline blood tests may be taken to assess your current autoimmune disease markers
- You will be counselled on potential risks and what to monitor at home
- Ongoing check-ins during dose escalation help catch any complications early
The MHRA's Black Triangle ▼ status means Mounjaro remains under enhanced safety monitoring, and all suspected adverse reactions can be reported directly to help build long-term safety evidence in autoimmune populations.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can I take Mounjaro if I have type 1 diabetes?
This requires specialist assessment. While some GLP-1 medications have been used in type 1 diabetes research, you must be reviewed by an endocrinologist or diabetes specialist. Tirzepatide is not standard for type 1 diabetes management, and insulin doses may need adjustment. Your specialist will determine if Mounjaro is appropriate for your individual case.
What autoimmune conditions would make me ineligible for Mounjaro?
There is no universal exclusion list. Each autoimmune condition — and each person — is assessed individually. Active, uncontrolled autoimmune disease may make prescription riskier, whilst stable, well-managed conditions may be compatible with Mounjaro. Your GP or prescriber will make this decision based on your medical history and current disease status.
Are there any autoimmune flare risks with Mounjaro?
Although GLP-1 and GIP/GLP-1 medications are generally considered anti-inflammatory, individual risk varies. Some case reports exist, but population-level data is limited. This is why enhanced MHRA monitoring is in place. Any new or worsening autoimmune symptoms during treatment should be reported to your GP immediately.
How is Mounjaro different from Wegovy for autoimmune patients?
Mounjaro uses a dual GIP/GLP-1 mechanism, whilst Wegovy (semaglutide) is a single GLP-1 agonist. Wegovy has longer real-world use in various populations, including some with autoimmune conditions, whilst tirzepatide data is more recent. Your prescriber will choose based on your individual profile, not just the mechanism.
What should I monitor if I start Mounjaro with an autoimmune condition?
Report new or worsening joint pain, unexplained fatigue, new rashes, or changes in your autoimmune disease activity. Keep regular appointments with your GP and autoimmune disease specialist. Blood tests may be scheduled to check inflammation markers. Use our free BMI calculator and progress tracker to document overall health changes alongside weight loss.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.